UNC80
protein-codingunc-80 homolog, NALCN channel complex subunit
Gene summary
The protein encoded by this gene is a component of a voltage-independent 'leak' ion-channel complex, in which it performs essential functions, such as serving as a bridge between two other components (sodium leak channel non-selective and UNC79) and as a scaffold for Src kinases. Leak channels play an importnat role in establishment and maintenance of resting membrane potentials in neurons. Mutations in this gene are associated with congenital infantile encephalopathy, intellectual disability and growth issues. [provided by RefSeq, Aug 2016]
- C2orf21
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~227.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014777
Submitter: Illumina
The UNC80 gene is located on chromosome 2 at 2q34 and encodes unc-80 homolog, NALCN channel complex subunit, which is a component of a sodium channel complex that regulates channel activity. UNC80 was first reported in relation to autosomal recessive UNC80-related hypotonia, infantile, with psychomotor retardation and characteristic facies, in 2016 (26708753: Shamseldin et al., 2016; 26708751: Stray-Pedersen et al. 2016). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 11 unique variants reported in eight cases from four publications (26708753: Shamseldin et al. 2016; 26708751: Stray-Pedersen et al. 2016; 30167850: Bramswig et al. 2018; 30771478: Kuptanon et al. 2019) One variant was a missense with experimental evidence of a loss-of-function effect; the remainder were predicted null variants. No segregation evidence was scored, but variants in this gene co-segregated with disease in three additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. Homozygous loss of function is implicated as the mechanism of disease. This gene-disease relationship is supported by knockout/knockdown models in C. Elegans and Drosophila, including rescue, as well as demonstration of physical interaction with another gene product associated with a similar phenotype (18336069: Yeh et al. 2008; 24223770: Lear et al. 2013). In summary, UNC80 is definitively associated with autosomal recessive UNC80-related hypotonia, infantile, with psychomotor retardation and characteristic facies. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0014777
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014176
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014777
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014777
Submitter: ClinGen
The UNC80 gene is located on chromosome 2 at 2q34 and encodes unc-80 homolog, NALCN channel complex subunit, which is a component of a sodium channel complex that regulates channel activity. UNC80 was first reported in relation to autosomal recessive hypotonia, infantile, with psychomotor retardation and characteristic facies 2 in 2016 (Shamseldin et al., 26708753; Stray-Pedersen et al., 26708751). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 11 unique variants reported in eight cases from four publications (26708753: Shamseldin et al. 2016; 26708751: Stray-Pedersen et al. 2016; 30167850: Bramswig et al. 2018; 30771478: Kuptanon et al. 2019). One variant was a missense with experimental evidence of a loss-of-function effect; the remainder were predicted null variants. No segregation evidence was scored, but variants in this gene co-segregated with disease in three additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. Biallelic loss of function is implicated as the mechanism of disease. This gene-disease relationship is supported by knockout/knockdown models in C. elegans and Drosophila, including rescue in C.elegans with the model organism gene, as well as demonstration of an effect on trafficking of the UNC80 protein and sodium NALCN-dependent sodium leak current (18336069: Yeh et al. 2008; 24223770: Lear et al. 2013; 32620897: Wie et al. 2020). In summary, UNC80 is definitively associated with autosomal recessive hypotonia, infantile, with psychomotor retardation and characteristic facies 2. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 4Nov2020 (SOP Version 7).
Inheritance Pattern: AR
Disease ID:MONDO:0014777
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to UNC80 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001371986.1. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 20 | 749 | 21 | 790 | ||
| missense | 8 | 1004 | 42 | 9 | 1063 | |
| nonsense | 46 | 13 | 1 | 60 | ||
| start loss | 1 | 1 | ||||
| frameshift | 31 | 11 | 5 | 47 | ||
| splice donor/acceptor (+/-2bp) | 4 | 40 | 4 | 48 | ||
| Total | 81 | 72 | 1035 | 791 | 30 | 2009 |
Highest pathogenic variant AF is 0.00004956869
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001358915.1 | 65 | MANE Select | |
| Ensembl | ENSP00000501211.1 | 65 | MANE Select | |
| RefSeq | NP_115893.1 | 64 | Standard | |
| RefSeq | NP_872393.3 | 63 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Stimuli-sensing channels
- Ion channel transport
- Transport of small molecules
Biological Process
- ion transmembrane transport
Cellular Component
- plasma membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000439458
- Coding exons
- 64
- Length
- 227308
- Individuals with no LoFs
- 125726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 19
- Defined
- 125745
- p
- 0.0000756
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.53 | 1089 | 1.74e+3 | 0.627 | 0.0000996 | 21316 |
| Missense (PolyPhen) | 591 | 1021.7 | 0.57846 | 12466 | ||
| Synonymous | 3.79 | 539 | 663 | 0.813 | 0.0000382 | 6422 |
| Loss of Function | 9.12 | 39 | 166 | 0.235 | 0.0000100 | 1901 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00013 | 0.00013 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the NALCN sodium channel complex, required for channel regulation. This complex is a cation channel activated by neuropeptides substance P, neurotensin, and extracellular calcium that regulates neuronal excitability by controlling the sizes of NALCN-dependent sodium-leak current. UNC80 is essential for NALCN sensitivity to extracellular calcium. {ECO:0000250|UniProtKB:Q8BLN6}.;
- Disease
- DISEASE: Hypotonia, infantile, with psychomotor retardation and characteristic facies 2 (IHPRF2) [MIM:616801]: An autosomal recessive, neurodegenerative disease characterized by severe truncal hypotonia since birth or early infancy, progressive peripheral spasticity, and profound psychomotor developmental delay. Some patients may have seizures. {ECO:0000269|PubMed:26545877, ECO:0000269|PubMed:26708751, ECO:0000269|PubMed:26708753}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.640
- RVIS EVS
- 0.99
- RVIS percentile EVS
- 90.5
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.231
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |